SNT 📈 Synektik S.A. - Overview
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLSNKTK00019
SNT: Medical Equipment, IT Solutions, Radiopharmaceutical Products
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as researches, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, the company operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. Further, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland. Web URL: https://www.synektik.com.pl
Additional Sources for SNT Stock
SNT Stock Overview
| Market Cap in USD | 406m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception |
SNT Stock Ratings
| Growth 5y | 94.8% |
| Fundamental | 41.5% |
| Dividend | 75.8% |
| Rel. Strength Industry | 5238 |
| Analysts | - |
| Fair Price Momentum | 281.42 PLN |
| Fair Price DCF | 281.02 PLN |
SNT Dividends
| Dividend Yield 12m | 1.59% |
| Yield on Cost 5y | 23.42% |
| Annual Growth 5y | 13.62% |
| Payout Consistency | 99.0% |
SNT Growth Ratios
| Growth Correlation 3m | -18.5% |
| Growth Correlation 12m | 87.1% |
| Growth Correlation 5y | 89% |
| CAGR 5y | 71.19% |
| CAGR/Mean DD 5y | 4.41 |
| Sharpe Ratio 12m | 1.94 |
| Alpha | 114.04 |
| Beta | 0.39 |
| Volatility | 39.02% |
| Current Volume | 12.9k |
| Average Volume 20d | 19.2k |
What is the price of SNT stocks?
As of December 22, 2024, the stock is trading at PLN 189.40 with a total of 12,857 shares traded.
Over the past week, the price has changed by -0.52%, over one month by +12.50%, over three months by +5.76% and over the past year by +124.46%.
As of December 22, 2024, the stock is trading at PLN 189.40 with a total of 12,857 shares traded.
Over the past week, the price has changed by -0.52%, over one month by +12.50%, over three months by +5.76% and over the past year by +124.46%.
Is Synektik S.A. a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Synektik S.A. (WAR:SNT) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.53 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SNT as of December 2024 is 281.42. This means that SNT is currently undervalued and has a potential upside of +48.59% (Margin of Safety).
Partly, yes. Based on ValueRay Fundamental Analyses, Synektik S.A. (WAR:SNT) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.53 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SNT as of December 2024 is 281.42. This means that SNT is currently undervalued and has a potential upside of +48.59% (Margin of Safety).
Is SNT a buy, sell or hold?
Synektik S.A. has no consensus analysts rating.
Synektik S.A. has no consensus analysts rating.
What are the forecast for SNT stock price target?
According to ValueRays Forecast Model, SNT Synektik S.A. will be worth about 307 in December 2025. The stock is currently trading at 189.40. This means that the stock has a potential upside of +62.08%.
According to ValueRays Forecast Model, SNT Synektik S.A. will be worth about 307 in December 2025. The stock is currently trading at 189.40. This means that the stock has a potential upside of +62.08%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 209.1 | 10.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 307 | 62.1% |